[go: up one dir, main page]

WO2008152994A1 - 医療用吸着剤 - Google Patents

医療用吸着剤 Download PDF

Info

Publication number
WO2008152994A1
WO2008152994A1 PCT/JP2008/060514 JP2008060514W WO2008152994A1 WO 2008152994 A1 WO2008152994 A1 WO 2008152994A1 JP 2008060514 W JP2008060514 W JP 2008060514W WO 2008152994 A1 WO2008152994 A1 WO 2008152994A1
Authority
WO
WIPO (PCT)
Prior art keywords
medical use
adsorbent
less
high adsorption
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/060514
Other languages
English (en)
French (fr)
Inventor
Takao Mizunoya
Mitsuhiro Saitoh
Toshio Shimizu
Isao Hamasaki
Motoya Mouri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TEIKOKUMEDIX Co Ltd
Original Assignee
TEIKOKUMEDIX Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TEIKOKUMEDIX Co Ltd filed Critical TEIKOKUMEDIX Co Ltd
Publication of WO2008152994A1 publication Critical patent/WO2008152994A1/ja
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/44—Elemental carbon, e.g. charcoal, carbon black
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Carbon And Carbon Compounds (AREA)
  • External Artificial Organs (AREA)

Abstract

【課題】本発明の課題は、毒素物質の吸着性能が高く吸着速度も速い医療用球形吸着炭を提供することにある。 【解決手段】粒状フェノール系樹脂を原料とし、全酸性基量が０．１６ｍｅｑ／ｇ以下、窒素雰囲気下１００°Cから９００°Cまで加熱した時の重量減少率が２％以下、直径０．００７５～１５μｍの細孔容積が０．１～１．０ｍＬ／ｇ、ＢＥＴ比表面積が８００～２０００ｍ２／ｇ、平均粒子径が０．１～１．５ｍｍである活性炭からなる医療用吸着剤が前記課題を解決した。
PCT/JP2008/060514 2007-06-11 2008-06-09 医療用吸着剤 Ceased WO2008152994A1 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007153556A JP5144965B2 (ja) 2007-06-11 2007-06-11 医療用吸着剤
JP2007-153556 2007-06-11

Publications (1)

Publication Number Publication Date
WO2008152994A1 true WO2008152994A1 (ja) 2008-12-18

Family

ID=40129599

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/060514 Ceased WO2008152994A1 (ja) 2007-06-11 2008-06-09 医療用吸着剤

Country Status (3)

Country Link
JP (1) JP5144965B2 (ja)
TW (1) TWI404539B (ja)
WO (1) WO2008152994A1 (ja)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014129614A1 (ja) * 2013-02-22 2014-08-28 株式会社クレハ 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤
EP2601955A4 (en) * 2010-08-02 2015-02-18 Asahi Organic Chem Ind ADSORBENT FOR ORAL ADMINISTRATION, MANUFACTURING METHOD THEREOF AND MEDICAMENT USING THE SAME
US9877987B2 (en) 2013-02-22 2018-01-30 Kureha Corporation Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
WO2021186579A1 (ja) * 2020-03-17 2021-09-23 株式会社大木工藝 経口摂取用吸着剤およびその製造方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5352378B2 (ja) * 2009-08-10 2013-11-27 マイラン製薬株式会社 吸着特性に優れた経口投与用吸着剤
JP5376592B2 (ja) * 2009-10-15 2013-12-25 産協企業有限股▲ふん▼公司 球形活性炭及びその製造方法
JP5466483B2 (ja) * 2009-10-15 2014-04-09 産協企業有限股▲ふん▼公司 球形活性炭及びその製造方法
JP5765649B2 (ja) 2010-03-10 2015-08-19 株式会社ダステック 吸着炭及び吸着剤
JP5984352B2 (ja) 2010-10-12 2016-09-06 フタムラ化学株式会社 経口投与用医薬用吸着剤の製造方法
WO2012121202A1 (ja) 2011-03-04 2012-09-13 株式会社クレハ 錠剤型の経口投与用組成物及びその製造方法
JP2014024817A (ja) * 2012-07-30 2014-02-06 Nippon Kayaku Food Techno Kk 慢性腎不全予防剤又は慢性腎不全治療剤
JP7008540B2 (ja) 2018-03-01 2022-01-25 株式会社クレハ 毒素分離器具
JP7228498B2 (ja) 2018-10-24 2023-02-24 フタムラ化学株式会社 フェノール樹脂の製造方法
CN113874320B (zh) 2019-04-16 2023-12-19 二村化学株式会社 活性炭吸附剂的制造方法
JP7438897B2 (ja) * 2020-08-26 2024-02-27 フタムラ化学株式会社 経口投与用錠剤型吸着剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094845A1 (ja) * 2004-04-02 2005-10-13 Kureha Corporation 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤
JP2005314415A (ja) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005094845A1 (ja) * 2004-04-02 2005-10-13 Kureha Corporation 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤
JP2005314416A (ja) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤
JP2005314415A (ja) * 2004-04-02 2005-11-10 Kureha Chem Ind Co Ltd 経口投与用吸着剤、並びに腎疾患治療又は予防剤、及び肝疾患治療又は予防剤

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2601955A4 (en) * 2010-08-02 2015-02-18 Asahi Organic Chem Ind ADSORBENT FOR ORAL ADMINISTRATION, MANUFACTURING METHOD THEREOF AND MEDICAMENT USING THE SAME
WO2014129614A1 (ja) * 2013-02-22 2014-08-28 株式会社クレハ 経口投与用吸着剤並びに腎疾患治療剤及び肝疾患治療剤
US9877987B2 (en) 2013-02-22 2018-01-30 Kureha Corporation Orally administered adsorbent, therapeutic agent for renal disease, and therapeutic agent for liver disease
WO2021186579A1 (ja) * 2020-03-17 2021-09-23 株式会社大木工藝 経口摂取用吸着剤およびその製造方法
CN114760991A (zh) * 2020-03-17 2022-07-15 株式会社大木工艺 经口摄入用吸附剂及其制造方法

Also Published As

Publication number Publication date
TWI404539B (zh) 2013-08-11
TW200911276A (en) 2009-03-16
JP2008303193A (ja) 2008-12-18
JP5144965B2 (ja) 2013-02-13

Similar Documents

Publication Publication Date Title
WO2008152994A1 (ja) 医療用吸着剤
CA2504517A1 (en) Adsorbent for oral administration, and agent for treating or preventing renal or liver disease
CN104671738B (zh) 一种页岩硅藻泥壁材及其制备方法
RU2007137631A (ru) Высокоэффективные адсорбенты на основе активированного угля с высокой микропористостью
WO2009060143A3 (fr) Materiau cristallise a porosite hierarchisee et comprenant du silicium
KR20040088532A (ko) 다기능 보호 재료 및 그 이용 방법
EP2138230A3 (en) Free Radical Post-Crosslinked Adsorbent and Method of Preparation
ZA200908593B (en) Spherical agglomerates based on zeolite(s), process for the production thereof and use thereof in adsorption processes or in catalysis
WO2009020334A3 (en) Porous polymer particles immobilized with charged molecules and method for preparing the same
JP2011518337A5 (ja)
WO2010054715A3 (de) Adsorptive strukturen und ihre verwendung
WO2011015429A3 (en) Antimicrobial material for water sterilization comprising a polyamide carrier and elemental silver nanoparticles
MY177923A (en) Medical adsorbent and method for producing same
EP2138229A3 (en) Friedel-Crafts Post-Crosslinked Adsorbent and Method of Preparation
UA102535C2 (ru) Электрод для емкостной деионизации
HK1242919A1 (zh) 包含纳米颗粒的聚合杂化物颗粒和用途
WO2008094897A3 (en) Catheters and medical balloons
Acevedo et al. Efficiency study of silver nanoparticles (AgNPs) supported on granular activated carbon against Escherichia coli
WO2010037967A3 (fr) Procede de traitement d'un gaz pour diminuer sa teneur en dioxyde de carbone
IN2012DN03184A (ja)
WO2009132912A3 (en) Surface-modified superparamagnetic oxidic particles
Solomon The emergence of nanotechnology and its applications
WO2008055855A3 (de) Photonische kristalle aus ungeladenen polymerteilchen
WO2012125642A3 (en) Filled porous membrane
CA2504514A1 (en) Adsorbent for oral administration

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08765315

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08765315

Country of ref document: EP

Kind code of ref document: A1